Correlation Engine 2.0
Clear Search sequence regions


  • amyloid (1)
  • brain (1)
  • hydrogen (2)
  • phase (1)
  • prion diseases (2)
  • prions (2)
  • PrP (13)
  • PrPC (2)
  • Sizes of these terms reflect their relevance to your search.

    Prion diseases are characterized by prion protein (PrP) transmissible aggregation and neurodegeneration, which has been linked to oxidative stress. The physiological function of PrP seems related to sequestering of redox-active Cu2+, and Cu2+ dyshomeostasis is observed in prion disease brain. It is unclear whether Cu2+ contributes to PrP aggregation, recently shown to be mediated by PrP condensation. This study indicates that Cu2+ promotes PrP condensation in live cells at the cell surface and in vitro through copartitioning. Molecularly, Cu2+ inhibited PrP β-structure and hydrophobic residues exposure. Oxidation, induced by H2O2, triggered liquid-to-solid transition of PrP:Cu2+ condensates and promoted amyloid-like PrP aggregation. In cells, overexpression of PrPC initially protected against Cu2+ cytotoxicity but led to PrPC aggregation upon extended copper exposure. Our data suggest that PrP condensates function as a buffer for copper that prevents copper toxicity but can transition into PrP aggregation at prolonged oxidative stress.

    Citation

    Mariana Juliani do Amaral, Satabdee Mohapatra, Aline Ribeiro Passos, Taiana Sousa Lopes da Silva, Renato Sampaio Carvalho, Marcius da Silva Almeida, Anderson Sá Pinheiro, Susanne Wegmann, Yraima Cordeiro. Copper drives prion protein phase separation and modulates aggregation. Science advances. 2023 Nov 03;9(44):eadi7347

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37922348

    View Full Text